Development of an in vitro periodontal biofilm model for assessing antimicrobial and host modulatory effects of bioactive molecules

BMC Oral Health

Volumn 14, Issue 1, 2014, Pages

  Millhouse, Emma ^a   Jose, Anto ^a,b   Sherry, Leighann ^a   Lappin, David F ^a   Patel, Nisha ^b   Middleton, Andrew M ^b   Pratten, Jonathan ^b   Culshaw, Shauna ^a   Ramage, Gordon ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Biofilm; Epithelial cell; Periodontal disease

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; AUTACOID; CHLORHEXIDINE; IL8 PROTEIN, HUMAN; INTERLEUKIN 8; MESSENGER RNA; RESVERATROL; SALIVA SUBSTITUTE; STILBENE DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; BIOFILM; CELL LINE; COCULTURE; DOWN REGULATION; DRUG EFFECTS; EPITHELIUM CELL; FUSOBACTERIUM NUCLEATUM; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; KERATINOCYTE; MICROBIAL CONSORTIUM; MICROBIOLOGY; PERIODONTAL DISEASE; PHYSIOLOGY; PORPHYROMONAS GINGIVALIS; STREPTOCOCCUS MITIS;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTI-INFLAMMATORY AGENTS; BIOFILMS; CELL LINE; CHLORHEXIDINE; COCULTURE TECHNIQUES; DOWN-REGULATION; EPITHELIAL CELLS; FUSOBACTERIUM NUCLEATUM; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; KERATINOCYTES; MICROBIAL CONSORTIA; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; RNA, MESSENGER; SALIVA, ARTIFICIAL; STILBENES; STREPTOCOCCUS MITIS;

EID: 84902947707     PISSN: None     EISSN: 14726831     Source Type: Journal    
DOI: 10.1186/1472-6831-14-80     Document Type: Article

References (36)

1. Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 2010, 8(7):481-490.
2. Wade WG. The oral microbiome in health and disease. Pharmacol Res 2013, 69(1):137-143.
3. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL. Microbial complexes in subgingival plaque. J Clin Periodontol 1998, 25(2):134-144.
4. Zarco MF, Vess TJ, Ginsburg GS. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis 2012, 18(2):109-120.
5. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP, Curtis MA. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 2011, 10(5):497-506.
6. Fujise O, Hamachi T, Inoue K, Miura M, Maeda K. Microbiological markers for prediction and assessment of treatment outcome following non-surgical periodontal therapy. J Periodontol 2002, 73(11):1253-1259.
7. Herrera D. Chlorhexidine mouthwash reduces plaque and gingivitis. Evid Based Dent 2013, 14(1):17-18.
8. Palaska I, Papathanasiou E, Theoharides TC. Use of polyphenols in periodontal inflammation. Eur J Pharmacol 2013, 720(1-3):77-83.
9. Casati MZ, Algayer C, Cardoso da Cruz G, Ribeiro FV, Casarin RC, Pimentel SP, Cirano FR. Resveratrol decreases periodontal breakdown and modulates local levels of cytokines during periodontitis in rats. J Periodontol 2013, 84(10):e58-e64.
10. Shan Z, Yang G, Xiang W, Pei-Jun W, Bin Z. Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro. J Cancer Res Clin Oncol 2014, 140(3):371-374.
11. Pratten J, Smith AW, Wilson M. Response of single species biofilms and microcosm dental plaques to pulsing with chlorhexidine. J Antimicrob Chemother 1998, 42(4):453-459.
12. Tunney MM, Patrick S, Gorman SP, Nixon JR, Anderson N, Davis RI, Hanna D, Ramage G. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg (Br) 1998, 80(4):568-572.
13. Sherry L, Millhouse E, Lappin DF, Murray C, Culshaw S, Nile CJ, Ramage G. Investigating the biological properties of carbohydrate derived fulvic acid (CHD-FA) as a potential novel therapy for the management of oral biofilm infections. BMC Oral Health 2013, 13(1):47.
14. Erlandsen SL, Kristich CJ, Dunny GM, Wells CL. High-resolution visualization of the microbial glycocalyx with low-voltage scanning electron microscopy: dependence on cationic dyes. J Histochem Cytochem 2004, 52(11):1427-1435.
15. Ramage G, Milligan S, Lappin DF, Sherry L, Sweeney P, Williams C, Bagg J, Culshaw S. Antifungal, cytotoxic, and immunomodulatory properties of tea tree oil and its derivative components: potential role in management of oral candidosis in cancer patients. Front Microbiol 2012, 3:220.
16. Periasamy S, Chalmers NI, Du-Thumm L, Kolenbrander PE. Fusobacterium nucleatum ATCC 10953 requires Actinomyces naeslundii ATCC 43146 for growth on saliva in a three-species community that includes Streptococcus oralis 34. Appl Environ Microbiol 2009, 75(10):3250-3257.
17. Sanchez MC, Marin MJ, Figuero E, Llama-Palacios A, Leon R, Blanc V, Herrera D, Sanz M. Quantitative real-time PCR combined with propidium monoazide for the selective quantification of viable periodontal pathogens in an in vitro subgingival biofilm model. J Periodontal Res 2014, 49(1):20-28.
18. Boutaga K, van Winkelhoff AJ, Vandenbroucke-Grauls CM, Savelkoul PH. Comparison of real-time PCR and culture for detection of Porphyromonas gingivalis in subgingival plaque samples. J Clin Microbiol 2003, 41(11):4950-4954.
19. van der Reijden WA, Brunner J, Bosch-Tijhof CJ, van Trappen S, Rijnsburger MC, de Graaff MP, van Winkelhoff AJ, Cleenwerck I, de Vos P. Phylogenetic variation of Aggregatibacter actinomycetemcomitans serotype e reveals an aberrant distinct evolutionary stable lineage. Infect Genet Evol 2010, 10(7):1124-1131.
20. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, Louis DN, Li FP, Rheinwald JG. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000, 20(4):1436-1447.
21. Wollert T, Rollenhagen C, Langford GM, Sundstrom P. Human oral keratinocytes: a model system to analyze host-pathogen interactions. Methods Mol Biol 2012, 845:289-302.
22. Offenbacher S, Barros SP, Paquette DW, Winston JL, Biesbrock AR, Thomason RG, Gibb RD, Fulmer AW, Tiesman JP, Juhlin KD, Wang SL, Reichling TD, Chen KS, Ho B. Gingival transcriptome patterns during induction and resolution of experimental gingivitis in humans. J Periodontol 2009, 80(12):1963-1982.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
24. Dickinson BC, Moffatt CE, Hagerty D, Whitmore SE, Brown TA, Graves DT, Lamont RJ. Interaction of oral bacteria with gingival epithelial cell multilayers. Mol Oral Microbiol 2011, 26(3):210-220.
25. Belibasakis GN, Thurnheer T, Bostanci N. Interleukin-8 responses of multi-layer gingival epithelia to subgingival biofilms: role of the " red complex" species. Plos One 2013, 8(12):e81581.
26. Peyyala R, Kirakodu SS, Novak KF, Ebersole JL. Oral epithelial cell responses to multispecies microbial biofilms. J Dent Res 2013, 92(3):235-240.
27. Jenkins S, Addy M, Wade W. The mechanism of action of chlorhexidine. A study of plaque growth on enamel inserts in vivo. J Clin Periodontol 1988, 15(7):415-424.
28. Turkoglu O, Becerik S, Emingil G, Kutukculer N, Baylas H, Atilla G. The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflamm Res 2009, 58(5):277-283.
29. Lee JH, Kim YG, Ryu SY, Cho MH, Lee J. Resveratrol Oligomers Inhibit biofilm formation of Escherichia coli O157:H7 and Pseudomonas aeruginosa. J Nat Prod 2014, 77(1):168-172.
30. Chan MM. Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol 2002, 63(2):99-104.
31. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 2002, 8(3):893-903.
32. Lappin DF, Murad M, Sherrabeh S, Ramage G. Increased plasma levels epithelial cell-derived neutrophil-activating peptide 78/CXCL5 in periodontitis patients undergoing supportive therapy. J Clin Periodontol 2011, 38(10):887-893.
33. Vergara D, Simeone P, Toraldo D, Del Boccio P, Vergaro V, Leporatti S, Pieragostino D, Tinelli A, De Domenico S, Alberti S, Urbani A, Salzet M, Santino A, Maffia M. Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells. Mol Biosyst 2012, 8(4):1078-1087.
34. Herbert KJ, Snow ET. Modulation of arsenic-induced epidermal growth factor receptor pathway signalling by resveratrol. Chem Biol Interact 2012, 198(1-3):38-48.
35. Kundu JK, Shin YK, Surh YJ. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochem Pharmacol 2006, 72(11):1506-1515.
36. Jeong JY, Silver M, Parnes A, Nikiforow S, Berliner N, Vanasse GJ. Resveratrol ameliorates TNFalpha-mediated suppression of erythropoiesis in human CD34(+) cells via modulation of NF-kappaB signalling. Br J Haematol 2011, 155(1):93-101.